|
|
||||||||
Basic Science Investigation |
1 Division of Radiological Sciences, Edward Mallinckrodt Institute of Radiology, St. Louis, Missouri; 2 Division of Geriatrics and Nutritional Science, Washington University School of Medicine, St. Louis, Missouri; and 3 Department of Internal Medicine and Division of Cardiothoracic Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Correspondence: For correspondence or reprints contact: Pilar Herrero, ME, MS, Cardiovascular Imaging Laboratory, Mallinckrodt Institute of Radiology, 510 S. Kingshighway Blvd., St. Louis, Missouri 63110. E-mail:HerreroP{at}mir.wustl.edu
The aim of this study was to investigate whether compartmental modeling of 1-11C-glucose PET kinetics can be used for noninvasive measurements of myocardial glucose metabolism beyond its initial extraction. Methods: 1-11C-Glucose and U-13C-glucose were injected simultaneously into 22 mongrel dogs under a wide range of metabolic states; this was followed by 1 h of PET data acquisition. Heart tissue samples were analyzed for 13C-glycogen content (nmol/g). Arterial and coronary sinus blood samples (ART/CS) were analyzed for glucose (µmol/mL), 11C-glucose, 11CO2, and 11C-total acidic metabolites (11C-lactate [LA] + 11CO2) (counts/min/mL) and were used to calculate myocardial fractions of (a) glucose and 1-11C-glucose extractions, EF(GLU) and EF(11C-GLU); (b) 11C-GLU and 11C-LA oxidation, OF(11C-GLU) and OF(11C-LA); (c) 11C-glycolsysis, GCF(11C-GLU); and (d) 11C-glycogen content, GNF(11C-GLU). On the basis of these measurements, a compartmental model (M) that accounts for the contribution of exogenous 11C-LA to myocardial 11C activity was implemented to measure M-EF(GLU), M-GCF(GLU), M-OF(GLU), M-GNF(GLU), and the fraction of myocardial glucose stored as glycogen M-GNF(GLU)/M-EF(GLU)). Results: ART/CS data showed the following: (a) A strong correlation was found between EF(11C-GLU) and EF(GLU) (r = 0.92, P < 0.0001; slope = 0.95, P = not significantly different from 1). (b) In interventions with high glucose extraction and oxidation, the contribution of OF(11C-GLU) to total oxidation was higher than that of OF(11C-LA) (P < 0.01). In contrast, in interventions in which glucose uptake and oxidation were inhibited, OF(11C-LA) was higher than OF(11C-GLU) (P < 0.05). (c) A strong correlation was found between GNF(11C-GLU)/EF(GLU) and direct measurements of fractional 13C-glycogen content, (r = 0.96, P < 0.0001). Model-derived PET measurements of M-EF(GLU), M-GCF(GLU), and M-OF(GLU) strongly correlated with EF(GLU) (slope = 0.92, r = 0.95, P < 0.0001), GCF(11C-GLU) (slope = 0.79, r = 0.97, P < 0.0001), and OF(11C-GLU) (slope = 0.70, r = 0.96, P < 0.0001), respectively. M-GNF(GLU)/M-EF(GLU) strongly correlated with fractional 13C-content (r = 0.92, P < 0.0001). Conclusion: Under nonischemic conditions, it is feasible to measure myocardial glucose metabolism noninvasively beyond its initial extraction with PET using 1-11C-glucose and a compartmental modeling approach that takes into account uptake and oxidation of secondarily labeled exogenous 11C-lactate.
Key Words: myocardial glucose metabolism 1-11C-glucose PET kinetic modeling
COPYRIGHT © 2007 by the Society of Nuclear Medicine, Inc.
Related articles in JNM:
This article has been cited by other articles:
![]() |
K. I. Shoghi, R. J. Gropler, T. Sharp, P. Herrero, N. Fettig, Y. Su, M. S. Mitra, A. Kovacs, B. N. Finck, and M. J. Welch Time Course of Alterations in Myocardial Glucose Utilization in the Zucker Diabetic Fatty Rat with Correlation to Gene Expression of Glucose Transporters: A Small-Animal PET Investigation J. Nucl. Med., August 1, 2008; 49(8): 1320 - 1327. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Herrero, C. S. Dence, A. R. Coggan, Z. Kisrieva-Ware, P. Eisenbeis, and R. J. Gropler L-3-11C-Lactate as a PET Tracer of Myocardial Lactate Metabolism: A Feasibility Study J. Nucl. Med., December 1, 2007; 48(12): 2046 - 2055. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |